ACE and chronic kidney disease: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor inhibitors (ARBs) are the preferred agents for treating hypertension in the CKD cohort due to their ability to delay the progression of CKD [11,12].